Dalian Institute of Chemical Physics, Chinese Academy of Sciences, 116023, Dalian, China.
University of Chinese Academy of Sciences, 100049 Beijing, China.
ACS Chem Biol. 2024 Sep 20;19(9):1868-1882. doi: 10.1021/acschembio.4c00110. Epub 2024 Aug 19.
-palmitoylation is a reversible and dynamic process that involves the addition of long-chain fatty acids to proteins. This protein modification regulates various aspects of protein function, including subcellular localization, stability, conformation, and biomolecular interactions. The zinc finger DHHC (ZDHHC) domain-containing protein family is the main group of enzymes responsible for catalyzing protein -palmitoylation, and 23 members have been identified in mammalian cells. Many proteins that undergo -palmitoylation have been linked to disease pathogenesis and progression, suggesting that the development of effective inhibitors is a promising therapeutic strategy. Reducing the protein -palmitoylation level can target either the PATs directly or their substrates. However, there are rare clinically effective -palmitoylation inhibitors. This review aims to provide an overview of the -palmitoylation field, including the catalytic mechanism of ZDHHC, -palmitoylation detection methods, and the functional impact of protein -palmitoylation. Additionally, this review focuses on current strategies for expanding the chemical toolbox to develop novel and effective inhibitors that can reduce the level of -palmitoylation of the target protein.
棕榈酰化是一种可逆和动态的过程,涉及到将长链脂肪酸添加到蛋白质中。这种蛋白质修饰调节蛋白质功能的各个方面,包括亚细胞定位、稳定性、构象和生物分子相互作用。锌指 DHHC(ZDHHC)结构域包含蛋白家族是催化蛋白质棕榈酰化的主要酶类,在哺乳动物细胞中已经鉴定出 23 个成员。许多经历棕榈酰化的蛋白质与疾病的发病机制和进展有关,这表明开发有效的抑制剂是一种有前途的治疗策略。降低蛋白质棕榈酰化水平可以直接针对 PATs 或它们的底物。然而,临床上有效的棕榈酰化抑制剂却很少。本文综述了棕榈酰化领域的研究进展,包括 ZDHHC 的催化机制、棕榈酰化检测方法以及蛋白质棕榈酰化的功能影响。此外,本文还重点介绍了目前扩展化学工具包的策略,以开发能够降低靶蛋白棕榈酰化水平的新型有效抑制剂。